Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
EMMPRIN/CD147 Antibody (MEM-M6/2) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB500561
Description
EMMPRIN/CD147 Monoclonal specifically detects EMMPRIN/CD147 in Human, Porcine samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Flow (Cell Surface), CyTOF-ready.Specifications
EMMPRIN/CD147 | |
Monoclonal | |
1.0 mg/mL | |
Flow Cytometry 4 μg/mL, Immunohistochemistry 1:10-1:500, Immunohistochemistry-Paraffin 10 μg/mL, Flow (Cell Surface), CyTOF-ready | |
BSG | |
A soluble recombinant form of CD147, CD147Rg, which consists of the cDNA coding for the entire extracellular region of CD147 fused to the DNA coding for the hinge region, CH2 and CH3 domain of human IgG1. | |
Protein A purified | |
RUO | |
Primary | |
The antibody MEM-M6/2 recognizes extracellular Ig domain D1 of CD147 (Neurothelin), a 50-60 kDa type I transmembrane glycoprotein primarily expressed on all leukocytes, red blood cells, platelets and endothelial cells; it is not expressed by resting lymphocytes. The antibody MEM-M6/1 is a high-affinity antibody capable of binding to unstimulated peripheral blood T cells. | |
Store at 4C. Do not freeze. | |
IgG2b |
Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Paraffin), CyTOF | |
MEM-M6/2 | |
Unconjugated | |
5F7, basigin, basigin (Ok blood group), CD147, CD147 antigen, Collagenase stimulatory factor, EMMPRINTCSF, Extracellular matrix metalloproteinase inducer, Leukocyte activation antigen M6, M6, OK, OK blood group antigen, Tumor cell-derived collagenase stimulatory factor | |
Mouse | |
60 kDa | |
0.1 mg | |
Cancer, Signal Transduction, Vision | |
682 | |
Human, Pig | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction